1. Home
  2. CRC vs IOVA Comparison

CRC vs IOVA Comparison

Compare CRC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$43.67

Market Cap

4.2B

Sector

Energy

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.76

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
IOVA
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRC
IOVA
Price
$43.67
$2.76
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$63.70
$10.45
AVG Volume (30 Days)
946.3K
11.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
3.72%
N/A
EPS Growth
N/A
N/A
EPS
4.29
N/A
Revenue
$3,505,000,000.00
$250,425,000.00
Revenue This Year
$20.33
$60.94
Revenue Next Year
N/A
$60.85
P/E Ratio
$10.16
N/A
Revenue Growth
34.91
175.62
52 Week Low
$30.97
$1.64
52 Week High
$58.41
$8.15

Technical Indicators

Market Signals
Indicator
CRC
IOVA
Relative Strength Index (RSI) 32.48 66.72
Support Level $44.45 $2.08
Resistance Level $45.87 $2.60
Average True Range (ATR) 1.34 0.15
MACD -0.38 0.04
Stochastic Oscillator 1.74 96.38

Price Performance

Historical Comparison
CRC
IOVA

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: